A strong focus on a treat-to-target strategy for gout is one of the key changes in new guideline released by the American College of Rheumatology (ACR) this week. In the first major update since 2012, new ACR guidelines now also include expanded indications for starting urate-lowering therapy (ULT), a focus on allopurinol as the preferred ...
Treat-to-target approach the focus of new ACR gout guidelines
By Michael Woodhead
12 May 2020